TNFRSF1A and melanoma: Of interest, all TNFR1-deficient mice (Supplementary Fig. 1) as well as WT mice injected with an anti-TNFR1 blocking antibody (Supplementary Fig. 2) rejected melanoma cells upon anti-PD-1 therapy.